Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#191 / 200 Total
SCYX - Scynexis Inc - Stock Price Chart
TickerSCYX [NASD]
CompanyScynexis Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap98.98MEPS (ttm)1.86
P/E1.41EPS this Y-115.54%
Forward P/E30.47EPS next Y139.81%
PEG-EPS past 5Y-
P/S0.71EPS next 5Y-
P/B1.34EPS Q/Q101.20%
Dividend-Sales Q/Q21.50%
Insider Own2.84%Inst Own39.29%
Insider Trans0.00%Inst Trans-0.19%
Short Float2.66%EarningsMay 08/a
Analyst Recom1.00Target Price6.88
Avg Volume239.49K52W Range1.35 - 3.87
May-08-24 11:54PM SCYX Stock Earnings: SCYNEXIS Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:51PM Scynexis: Q1 Earnings Snapshot (Associated Press Finance)
04:30PM SCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Apr-30-24 04:05PM SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID) (GlobeNewswire) -7.14%
Apr-16-24 11:52AM 14 Cheap Penny Stocks to Buy According to Analysts (Insider Monkey)
Apr-09-24 04:05PM SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) (GlobeNewswire)
Mar-28-24 11:53PM SCYX Stock Earnings: SCYNEXIS Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
04:01PM SCYNEXIS Reports Full Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Jan-30-24 04:05PM SCYNEXIS to Participate in Guggenheim's 6th Annual Biotechnology Conference (GlobeNewswire)
Jan-29-24 05:15PM SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 against Mucormycosis at the 11th Advances Against Aspergillosis and Mucormycosis Conference (GlobeNewswire)
AMJB - Alerian MLP Index ETNs - Stock Price Chart
TickerAMJB [NYSE]
CompanyAlerian MLP Index ETNs
CountryUSA
IndustryExchange Traded Fund
CategoryOther Asset Types - Multi-Asset / Other
IndexAlerian MLP Index
TagsU.S., equity, energy, infrastructure, transportation, MLP
Sector/Theme Region
Dividend1.47%Active/Passive
Total Holdings-AUM783.67M
Flows% 1M572.60%Flows% 3M572.60%
Flows% YTD572.60%Flows% 1Y
Return% 1Y-Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume94.55K52W Range25.84 - 31.90
May-09-24 04:30PM JPMorgan Announces Results of Exchange Offer Relating to Its Alerian MLP Index ETNs and Reminds Holders That the Remaining AMJ ETNs Will Mature May 24, 2024 (Business Wire)
Apr-15-24 09:00AM JPMorgan Announces Extension of Exchange Offer Relating to Its Alerian MLP Index ETNs (Business Wire)
Feb-21-24 04:15PM JPMorgan Chase Financial Company LLC Declares Quarterly Coupon on Alerian MLP Index ETN (Business Wire)
Feb-07-24 04:15PM JPMorgan Commences Exchange Offer Relating to its Alerian MLP Index ETNs (Business Wire)
KOCT - Innovator U.S. Small Cap Power Buffer ETF - October - Stock Price Chart
TickerKOCT [AMEX]
CompanyInnovator U.S. Small Cap Power Buffer ETF - October
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Quant Strat
IndexRussell 2000 Index
TagsU.S., options, Russell-2000, buffer, upside-cap, fixed-period
Sector/Theme Region
Dividend-Active/Passive
Total Holdings5AUM88.17M
Flows% 1M0.00%Flows% 3M-3.85%
Flows% YTD-5.25%Flows% 1Y
Return% 1Y11.05%Return% 3Y0.02%
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume7.15K52W Range24.40 - 29.07
Apr-01-20 09:00AM Innovator Expands Category-Creating Defined Outcome ETF Suite with April Series of Nasdaq 100 and Russell 2000 Power Buffer Listings, Announces New Upside Caps for April Series of S&P 500 Buffer ETFs (ACCESSWIRE) -6.17%
Mar-23-20 09:00AM Innovator Preps Defined Outcome ETF Expansion with April Series of Nasdaq 100, Russell 2000, MSCI EAFE, and Emerging Markets Power Buffer Listings, Announces New Upside Cap Ranges for April S&P 500 Buffer ETFs (ACCESSWIRE)
Mar-02-20 09:00AM Innovator Expands Defined Outcome Suite Listing March Series of S&P 500 Buffer ETFs (ACCESSWIRE)
Feb-21-20 09:00AM Innovator Announces Upside Cap Ranges for March Series of S&P 500 Buffer ETFs (ACCESSWIRE)
Feb-03-20 09:00AM Innovator Expands Defined Outcome Suite Listing February Series of S&P 500 Buffer ETFs (ACCESSWIRE)
Jan-27-20 09:00AM Innovator Announces Upside Cap Ranges for February Series of S&P 500 Buffer ETFs (ACCESSWIRE)
Jan-08-20 10:46AM Innovator Announces Successful Completion of Initial Outcome Period for January Series of S&P 500 Buffer ETFs (ACCESSWIRE)
Jan-02-20 09:00AM Innovator Expands Defined Outcome Suite Listing January Series of Nasdaq 100, Russell 2000, MSCI EAFE, and MSCI Emerging Markets Power Buffer ETFs (ACCESSWIRE)
Dec-31-19 07:00PM Innovator Announces New Upside Caps for January Series of S&P 500 Buffer ETFs (ACCESSWIRE)
Dec-27-19 09:00AM Innovator Preps Nasdaq 100, Russell 2000, MSCI EAFE, and MSCI Emerging Markets Buffer ETF Listings, Announces Upside Cap Ranges for S&P 500 January Series of Defined Outcome Buffer ETFs (ACCESSWIRE)
SCLX - Scilex Holding Company - Stock Price Chart
TickerSCLX [NASD]
CompanyScilex Holding Company
CountryUSA
IndustryDrug Manufacturers - General
Market Cap219.24MEPS (ttm)-0.89
P/E-EPS this Y49.61%
Forward P/E-EPS next Y37.21%
PEG-EPS past 5Y-
P/S4.66EPS next 5Y-
P/B-EPS Q/Q-9.63%
Dividend-Sales Q/Q2.85%
Insider Own38.07%Inst Own15.96%
Insider Trans0.38%Inst Trans-8.47%
Short Float7.68%Earnings-
Analyst Recom1.00Target Price6.25
Avg Volume1.03M52W Range0.73 - 8.37
May-14-24 09:00AM Scilex Holding Company Announces Final Court Approval of a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex's intent to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba (GlobeNewswire)
08:53AM SCLX Stock Earnings: Scilex Holding Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
May-13-24 09:00AM Scilex Holding Company Provides Information to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock (GlobeNewswire) +7.98%
Apr-25-24 04:01PM Scilex Holding Company Announces Closing of $15 Million Registered Direct Offering (GlobeNewswire)
Apr-24-24 08:00AM Scilex Holding Company Announces $15 Million Registered Direct Offering (GlobeNewswire) -12.97%
Apr-16-24 09:00AM Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expenses (GlobeNewswire) -9.38%
Apr-09-24 09:00AM Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido and ELYXYB for Commercially Insured Patients and the addition of ELYXYB to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing Pool (GlobeNewswire)
Mar-27-24 09:00AM Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend (GlobeNewswire) +6.62%
Mar-21-24 09:30AM Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients (GlobeNewswire)
Mar-20-24 11:00AM Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed (GlobeNewswire)
SAGE - Sage Therapeutics Inc - Stock Price Chart
TickerSAGE [NASD, RUT]
CompanySage Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap672.81MEPS (ttm)-8.40
P/E-EPS this Y28.60%
Forward P/E-EPS next Y22.02%
PEG-EPS past 5Y-2.28%
P/S7.39EPS next 5Y16.80%
P/B0.95EPS Q/Q26.68%
Dividend-Sales Q/Q139.89%
Insider Own17.78%Inst Own98.45%
Insider Trans0.00%Inst Trans0.73%
Short Float16.48%EarningsApr 25/b
Analyst Recom2.67Target Price22.24
Avg Volume1.01M52W Range10.92 - 59.99
May-13-24 07:57PM 15 Most Depressed States in the US (Insider Monkey)
May-07-24 06:30AM Sage Therapeutics to Participate in Upcoming May Investor Conferences (Business Wire)
Apr-30-24 12:57PM Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-26-24 11:27AM Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates (Zacks)
Apr-25-24 02:33PM Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained (MT Newswires)
10:54AM SAGE Stock Earnings: Sage Therapeutics Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:04AM Sage Therapeutics Inc (SAGE) Q1 2024 Earnings: Mixed Results Amidst Pipeline Progress (GuruFocus.com)
07:35AM Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
06:30AM Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress (Business Wire)
Apr-18-24 11:37AM Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal (Zacks)
BAOS - Baosheng Media Group Holdings Ltd - Stock Price Chart
TickerBAOS [NASD]
CompanyBaosheng Media Group Holdings Ltd
CountryChina
IndustryAdvertising Agencies
Market Cap5.45MEPS (ttm)-11.44
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.57EPS next 5Y-
P/B0.13EPS Q/Q99.79%
Dividend-Sales Q/Q243.44%
Insider Own58.14%Inst Own0.00%
Insider Trans0.00%Inst Trans-79.28%
Short Float0.07%Earnings-
Analyst Recom-Target Price-
Avg Volume27.51K52W Range3.03 - 14.51
May-10-23 06:06AM Baosheng Media Group Holdings Full Year 2022 Earnings: US$15.47 loss per share (vs US$4.62 loss in FY 2021) (Simply Wall St.)
Apr-07-23 08:00AM Baosheng Media Group Holdings Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Mar-21-23 01:00PM Baosheng Media Group Holdings Limited Announces Share Consolidation (GlobeNewswire)
Dec-21-22 08:00AM Baosheng Media Group Holdings Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire)
Oct-14-22 04:30PM Baosheng Media Group Holdings Limited Reports Financial Results for the First Half of 2022 (PR Newswire)
Jun-14-22 08:00AM Baosheng Media Group Holdings Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
May-24-22 04:05PM Baosheng Media Group Holdings Limited Announces Share Consolidation (GlobeNewswire) -5.42%
Feb-04-22 04:30PM Baosheng Media Group Holdings Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire)
Dec-15-21 09:01AM 11 Best One Dollar Stocks to Buy Today (Insider Monkey)
Nov-02-21 10:49AM BAOS Stock: 6 Things to Know About the China Penny Play Baosheng Media as Shares Soar (InvestorPlace) +21.02%
AILE - iLearningEngines Inc. - Stock Price Chart
TickerAILE [NASD]
CompanyiLearningEngines Inc.
CountryUSA
IndustrySoftware - Infrastructure
Market Cap76.76MEPS (ttm)-0.80
P/E-EPS this Y-10.00%
Forward P/E44.00EPS next Y372.73%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-1276.09%
Dividend-Sales Q/Q-
Insider Own84.01%Inst Own6.19%
Insider Trans0.00%Inst Trans1.36%
Short Float0.97%EarningsMay 16/a
Analyst Recom1.00Target Price19.50
Avg Volume21.87K52W Range6.16 - 20.00
May-16-24 05:30PM iLearningEngines Reports First Quarter 2024 Results (GlobeNewswire)
Apr-22-24 04:30PM iLearningEngines Reports Fourth Quarter and Full Year 2023 Results (GlobeNewswire)
Apr-18-24 06:30PM Nationwide Insurance to Showcase How they are Driving Proactive Risk Management Using iLearningEngines' Enterprise AI Platform at the 2024 Insurance Innovators Conference (GlobeNewswire) -28.90%
Apr-17-24 09:20AM iLearningEngines, Inc. Announces Additional Funding in Connection With Its Business Combination; Brings Gross Proceeds to Approximately $92.8 Million (GlobeNewswire) -44.44%
Apr-16-24 04:05PM iLearningEngines, Inc. Becomes Publicly Traded Company After Completing Business Combination With Arrowroot Acquisition Corp., Will Commence Trading on Nasdaq Under Ticker Symbol AILE (GlobeNewswire) +45.04%
Apr-01-24 04:05PM Arrowroot Acquisition Corp. Shareholders Approve Previously Announced Business Combination With iLearningEngines, Inc. (Business Wire) +19.82%
Mar-28-24 11:00AM iLearningEngines, Inc. to Add Michael Moe and Sir Ian Davis to its Board of Directors (Business Wire)
Mar-26-24 09:18PM Arrowroot Acquisition Corp. Announces Postponement of Special Meeting of Stockholders (PR Newswire) -13.50%
Mar-22-24 04:53PM Arrowroot Acquisition Corp. Announces Postponement of Special Meeting of Stockholders (PR Newswire)
Mar-13-24 04:15PM Arrowroot Acquisition Corp. Announces Postponement of Special Meeting of Stockholders and New Record Date of Special Meeting of Stockholders (PR Newswire)
BIGZ - BlackRock Innovation and Growth Term Trust - Stock Price Chart
TickerBIGZ [NYSE]
CompanyBlackRock Innovation and Growth Term Trust
CountryUSA
IndustryClosed-End Fund - Equity
Market Cap1.72BEPS (ttm)-0.40
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend7.40%Sales Q/Q-
Insider Own0.01%Inst Own27.43%
Insider Trans-Inst Trans-
Short Float0.08%Earnings-
Analyst Recom-Target Price-
Avg Volume613.17K52W Range6.21 - 8.35
Today 07:00AM Saba Capital Releases Presentation Detailing Plan to Deliver Enhanced Shareholder Value at 10 BlackRock Closed-End Funds (Business Wire)
06:00AM BlackRock Announces Increased Distribution Rates for Certain Closed-End Funds (Business Wire)
May-03-24 06:05PM Certain BlackRock Closed-End Funds Announce Adoption of Discount Management Program (Business Wire)
May-01-24 04:30PM Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds (Business Wire)
Apr-30-24 04:30PM Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions (Business Wire)
Jan-11-24 04:30PM BlackRock Closed-End Funds have Repurchased approximately $1.3 Billion of Shares since the Share Repurchase Programs Inception (Business Wire)
Nov-01-23 06:00PM Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds (Business Wire)
Oct-10-23 04:30PM BIGZ, BMEZ, BSTZ, BCAT, and ECAT Repurchased over $137 Million of Shares in 2023 (Business Wire)
Sep-08-23 04:30PM BlackRock Science and Technology Term Trust (BSTZ), BlackRock Health Sciences Term Trust (BMEZ) and BlackRock Innovation and Growth Term Trust (BIGZ) Announce Changes to Distribution Rates Under Managed Distribution Plans (Business Wire)
Aug-24-23 06:00PM BlackRock Announces Release of Commentaries for Certain Closed-End Funds (BIGZ, BSTZ, BMEZ, BCAT, ECAT, and BMN) and Private Investment Report (Business Wire)
MIRA - Mira Pharmaceuticals Inc - Stock Price Chart
TickerMIRA [NASD]
CompanyMira Pharmaceuticals Inc
CountryUSA
IndustryDrug Manufacturers - General
Market Cap12.56MEPS (ttm)-0.81
P/E-EPS this Y3.13%
Forward P/E-EPS next Y35.48%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B3.98EPS Q/Q4.18%
Dividend-Sales Q/Q-
Insider Own33.99%Inst Own3.87%
Insider Trans-4.52%Inst Trans-
Short Float0.42%Earnings-
Analyst Recom-Target Price-
Avg Volume586.88K52W Range0.63 - 7.98
Today 08:00AM Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2, a Differentiated Oral Ketamine Analog (PR Newswire) +29.77%
May-13-24 09:53PM MIRA Stock Earnings: Mira Pharmaceuticals Misses EPS for Q1 2024 (InvestorPlace)
Apr-02-24 08:00AM Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission (PR Newswire)
Apr-01-24 02:53PM MIRA Stock Earnings: Mira Pharmaceuticals Beats EPS for Q4 2023 (InvestorPlace)
Mar-21-24 11:04AM MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor (PR Newswire)
Mar-08-24 08:19AM Why Is Mira Pharmaceuticals (MIRA) Stock Up 52% Today? (InvestorPlace) +65.28%
Feb-05-24 08:30AM MIRA Pharmaceuticals Provides Corporate Update (PR Newswire) +45.99%
Dec-04-23 08:00AM MIRA Pharmaceuticals Releases Breakthrough Data from Artificial Intelligence Simulations (PR Newswire) -5.26%
Nov-29-23 08:00AM MIRA Pharmaceuticals Announces Ketamir-2's Oral Bioavailability Predicted to be 80% (PR Newswire)
Nov-21-23 10:42AM MIRA Pharmaceuticals To Host Shareholder Update Call on Tuesday, December 5, 2023 at 11:30 a.m. Eastern Time (PR Newswire) -16.13%
DOLE - Dole plc - Stock Price Chart
TickerDOLE [NYSE, RUT]
CompanyDole plc
CountryIreland
IndustryFarm Products
Market Cap1.24BEPS (ttm)1.53
P/E8.50EPS this Y-3.37%
Forward P/E9.34EPS next Y16.47%
PEG-EPS past 5Y-
P/S0.15EPS next 5Y-3.52%
P/B0.99EPS Q/Q143.28%
Dividend2.48%Sales Q/Q-12.05%
Insider Own35.23%Inst Own48.72%
Insider Trans0.00%Inst Trans-10.86%
Short Float2.73%EarningsMay 15/b
Analyst Recom1.50Target Price15.73
Avg Volume497.17K52W Range10.55 - 14.01
May-16-24 03:01AM Q1 2024 Dole PLC Earnings Call (Thomson Reuters StreetEvents)
May-15-24 10:53AM DOLE Stock Earnings: Dole Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
07:10AM Dole (DOLE) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
06:15AM Dole (NYSE:DOLE) Reports Q1 In Line With Expectations (StockStory)
06:00AM Dole plc Reports First Quarter 2024 Financial Results (Business Wire)
May-14-24 05:36PM CPI data, Fedspeak, Cisco earnings: What to Watch (Yahoo Finance Video)
03:01AM Dole (DOLE) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Apr-24-24 06:00AM Dole plc Schedules First Quarter 2024 Earnings Release (Business Wire)
Mar-28-24 06:38AM Dole plc 2023 Annual Report Available to Shareholders (Business Wire)
06:00AM Dole plc Announces Mutual Termination of Agreement with Fresh Express for the Sale of its Fresh Vegetables Division (Business Wire)
1⋯10⋯151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.